drug · small molecule
LB-102
Phase 3updated 3mo agoby $LBRX LB PHARMACEUTICALS INC🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 2, with 1 investigational indication.
indications
indications
Schizophrenia
all catalysts(0)
nothing on the calendar yet
Trials studying LB-102
- phase2Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
- phase352-week Open Label Safety-Tolerability Study
- phase3Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- phase2Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 20m ago
Found something off?
comments(0)
5-min edit window · permanent after that